Jonathan Insel
Endocrinology, Diabetes & Metabolism · Tucson, AZNPI 1053350728
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 455 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 45 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,374 and has fallen 78.3% since, to $515 in 2023.
Across 455 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$994
- Novo Nordisk$807
- Abbott$545
- Corcept Therapeutics$460
- Mannkind Corporation$443
- Sanofi-aventis U.S. LLC$407
- plus $4K from 39 others
What the payments were for
- Food & beverage$7,43399%
- Education$441%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Korlym$234
- FreeStyle Libre 2$125
How this compares
$7,477 in reported general payments places this provider in the 70th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
See all endocrinology, diabetes & metabolism providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 17 | $19,631 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $17,299 |
| JardianceEmpagliflozin | 14 | $10,821 |
| SynthroidLevothyroxine Sodium | 38 | $4,821 |
| HumalogInsulin Lispro | 13 | $2,959 |
| Levothyroxine Sodium | 126 | $1,452 |
| Metformin Hcl ErMetformin Hcl | 30 | $415 |
| Rosuvastatin Calcium | 34 | $285 |
| Ezetimibe | 14 | $243 |
| Amlodipine Besylate | 25 | $223 |
| Methimazole | 18 | $204 |
| Simvastatin | 13 | $192 |
| Losartan Potassium | 18 | $181 |
| Spironolactone | 15 | $170 |
| Lisinopril | 15 | $156 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $807 | $19,63117 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $407 | $17,29911 claims |
| Boehringer IngelheimJardiance | $366 | $10,82114 claims |
| AbbVieSynthroid | $331 | $4,82138 claims |
| Lilly USA, LLCHumalog | $384 | $2,95913 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $84 | $1,452126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
Other endocrinology, diabetes & metabolism in Tucson
- Muhammad SethiTucson$670K
- Karen HerbstTucson$200K
- Nora BarsonyTucson$121K
- Maria PosadasTucson$24K
- Dorota PucykTucson$15K
- Neda EbrahimiTucson$11K
- Casey RendonTucson$9K
- Roshanak HabibiTucson$7K
- Ramiro Cardenas LaraTucson$6K
- Cynthia Rivas PajueloTucson$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.